bcr_patient_barcode	additional_pharmaceutical_therapy	additional_radiation_therapy	additional_surgery_locoregional_procedure	additional_treatment_completion_success_outcome_type	age_began_smoking_in_years	anatomic_site_location_descriptor	bcr_patient_uuid	bladder_carcinoma_clinical_stage	bladder_carcinoma_clinical_t_stage	bladder_carcinoma_extracapsular_extension_status	bladder_carcinoma_other_metastatic_involvement_anatomic_site_text	bladder_carcinoma_pathologic_m_stage	bladder_carcinoma_pathologic_n_stage	bladder_carcinoma_pathologic_t_stage	bladder_malignant_neoplasm_metastatic_involvement_site	bladder_tumor_histologic_who_2004_grade	blood_relative_cancer_history_list	chemical_exposure_text	date_of_additional_surgery_metastatic_procedure	date_of_birth	date_of_death	date_of_form_completion	date_of_initial_pathologic_diagnosis	date_of_last_followup	date_of_last_known_alive	date_of_new_tumor_event_after_initial_treatment	diagnostic_ct_result_outcomes	disease_extracapsular_extension_ind-3	ethnicity	first_pathologic_diagnosis_biospecimen_acquisition_other_method_text	gender	gleason_score_combined_pattern_value	height	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	initial_pathologic_diagnosis_method	karnofsky_performance_status_score	lymph_node_examined_count	new_neoplasm_event_occurrence_anatomic_site	new_neoplasm_event_type	new_neoplasm_occurrence_anatomic_site_text	occupation_primary_job	patient_id	patient_smoking_history_category	performance_status_assessment_eastern_cooperative_oncology_group_scale	person_cigarette_smoking_history_pack_year_value	person_concomitant_prostate_carcinoma_occurrence_indicator	person_concomitant_prostate_carcinoma_pathologic_t_stage	person_neoplasm_cancer_status	person_occupation_description_text	person_occupation_years_number	person_primary_industry_text	positive_finding_lymph_node_hematoxylin_and_eosin_staining_microscopy_count	pretreatment_history	primary_therapy_outcome_success_type	prior_diagnosis	race	radiation_therapy	specimen_histologic_type_type_histologictype	stopped_smoking_year	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tumor_histologic_subtype_type	tumor_lymphovascular_invasion_ind	tumor_tissue_site	vital_status	weight	ajcc_cancer_metastasis_stage_code	ajcc_cancer_staging_handbook_edition	ajcc_neoplasm_disease_lymph_node_stage	ajcc_neoplasm_disease_stage	ajcc_tumor_stage_code	anatomic_organ_subdivision	axillary_lymph_node_stage_method_type	axillary_lymph_node_stage_other_method_descriptive_text	breast_cancer_optical_measurement_histologic_type	breast_cancer_surgery_margin_status	breast_carcinoma_estrogen_receptor_status	breast_carcinoma_immunohistochemistry_er_pos_finding_scale	breast_carcinoma_immunohistochemistry_pos_cell_score	breast_carcinoma_immunohistochemistry_progesterone_receptor_pos_finding_scale	breast_carcinoma_primary_surgical_procedure_name	breast_carcinoma_progesterone_receptor_status	breast_carcinoma_surgical_procedure_name	breast_neoplasm_other_surgical_procedure_descriptive_text	cytokeratin_immunohistochemistry_staining_method_micrometastasis_indicator	diagnostic_ct_result_outcome	distant_metastasis_present_ind2	er_detection_method_text	er_level_cell_percentage_category	first_nonlymph_node_metastasis_anatomic_site	first_recurrent_non_nodal_metastatic_anatomic_site_descriptive_text	fluorescence_in_situ_hybridization_diagnostic_procedure_chromosome_17_signal_result_range	her2_and_centromere_17_positive_finding_other_measurement_scale_text	her2_erbb_method_calculation_method_text	her2_erbb_pos_finding_cell_percent_category	her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text	her2_immunohistochemistry_level_result	her2_neu_and_centromere_17_copy_number_analysis_input_total_number_count	her2_neu_and_centromere_17_copy_number_metastatic_breast_carcinoma_analysis_input_total_number_count	her2_neu_breast_carcinoma_copy_analysis_input_total_number	her2_neu_chromosone_17_signal_ratio_value	her2_neu_metastatic_breast_carcinoma_copy_analysis_input_total_number	immunohistochemistry_positive_cell_score	lab_proc_her2_neu_immunohistochemistry_receptor_status	lab_procedure_her2_neu_in_situ_hybrid_outcome_type	margin_status	menopause_status	metastatic_breast_carcinoma_erbb2_immunohistochemistry_level_result	metastatic_breast_carcinoma_estrogen_receptor_detection_method_text	metastatic_breast_carcinoma_estrogen_receptor_level_cell_percent_category	metastatic_breast_carcinoma_estrogen_receptor_status	metastatic_breast_carcinoma_fluorescence_in_situ_hybridization_diagnostic_proc_centromere_17_signal_result_range	metastatic_breast_carcinoma_her2_erbb_method_calculation_method_text	metastatic_breast_carcinoma_her2_erbb_pos_finding_cell_percent_category	metastatic_breast_carcinoma_her2_erbb_pos_finding_fluorescence_in_situ_hybridization_calculation_method_text	metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_ratio_value	metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_score	metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_score	metastatic_breast_carcinoma_lab_proc_her2_neu_immunohistochemistry_receptor_status	metastatic_breast_carcinoma_lab_proc_her2_neu_in_situ_hybridization_outcome_type	metastatic_breast_carcinoma_pos_finding_her2_erbb2_other_measure_scale_text	metastatic_breast_carcinoma_pos_finding_other_scale_measurement_text	metastatic_breast_carcinoma_pos_finding_progesterone_receptor_other_measure_scale_text	metastatic_breast_carcinoma_progesterone_receptor_detection_method_text	metastatic_breast_carcinoma_progesterone_receptor_level_cell_percent_category	metastatic_breast_carcinoma_progesterone_receptor_status	number_of_lymphnodes_positive_by_he	number_of_lymphnodes_positive_by_ihc	pgr_detection_method_text	pos_finding_her2_erbb2_other_measurement_scale_text	pos_finding_metastatic_breast_carcinoma_estrogen_receptor_other_measuremenet_scale_text	pos_finding_progesterone_receptor_other_measurement_scale_text	positive_finding_estrogen_receptor_other_measurement_scale_text	primary_lymph_node_presentation_assessment	primary_other_site_of_disease_name	progesterone_receptor_level_cell_percent_category	surgical_procedure_purpose_other_text	tumor_other_histologic_subtype_descriptive_text
TCGA-00-1111	[Not Applicable]	[Not Applicable]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	4881C961-7280-460D-BCCC-CBC59D84591D	Stage II	[Not Available]	[Not Available]	[Not Applicable]	M0	pN0	pT2b	[Not Available]	High Grade	null	[Not Available]	NA	1946-8-00	NA	2010-8-19	2007-2-00	NA	NA	NA	null	[Not Available]	[Not Available]	Surgical resection	MALE	[Not Available]	[Not Available]	[Not Available]	8120/3	c67.9	YES	OTHER METHOD, SPECIFY IN NOTES	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	A0F0	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	NO	[Not Available]	NO	[Not Available]	[Not Available]	Non-Papillary	[Not Applicable]	NO	YES	C4	Muscle invasive urothelial carcinoma	[Not Available]	BLADDER	[Not Available]	[Not Available]
